ACR
ACRES Commercial Realty Corp.
Set alert
- YTD
- -39.60%
- 1 year
- -38.03%
- Open
- 12.80
- Prev close
- 12.74
- Mkt cap
- 202.02M
- Vol
- 33.21K
- Avg vol
- 43.34K
- EPS
- -1.09
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 12.81
- High
- 13.12
- Forward P/E
- 8.32
- Beta
- 2.05
- Short ratio
- 0.79
- Inst. own
- 35.82%
- Dividend
- 0.00
- Ex-div date
- Dec 29, 2019
- 50-d avg
- 16.28
- 200-d avg
- 14.60
- 1y target
- 19.50
Key statistics
- Market cap
- 122.24M
- Enterprise value
- 1.59B
- Trailing P/E
- 19.04
- Forward P/E
- 8.32
- PEG ratio
- 0.00
- Price / sales
- 1.58
- Price / book
- 0.26
- EPS (TTM)
- 0.83
- Beta
- 2.05
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 33.95%
- Revenue (TTM)
- 77.44M
- Revenue growth
- 2.80%
- Free cash flow
- 0
- Total cash
- 70.07M
- Total debt
- 1.53B
- Return on equity
- 5.77%
- Shares outstanding
- 7.74M
- Short % of float
- 0.29%
- 50-day average
- 16.28
- 200-day average
- 14.60
Analyst view
Consensus: none
- Target (low)
- 18.00
- Target (mean)
- 19.50
- Target (high)
- 21.00
- Strong buy2
- Buy0
- Hold1
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate 0.38.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Oct 30, 2024 | Sep 1, 2024 | 0.39 | 0.24 | -0.15 | -38.46% |
| Jul 31, 2024 | Jun 1, 2024 | 0.35 | 0.51 | +0.16 | +45.71% |
| May 1, 2024 | Mar 1, 2024 | 0.42 | 0.16 | -0.26 | -61.90% |
| Feb 28, 2024 | Dec 1, 2023 | 0.58 | 0.55 | -0.03 | -5.17% |
| Nov 1, 2023 | Sep 1, 2023 | 0.53 | 0.73 | +0.20 | +37.74% |
| Aug 2, 2023 | Jun 1, 2023 | 0.47 | 0.60 | +0.13 | +27.66% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 8, 2024 | Jones Trading | init | — | Hold |
| Oct 7, 2024 | Jones Trading | init | — | Hold |
| Sep 25, 2024 | JMP Securities | main | Market Outperform | Market Outperform |
| Apr 30, 2024 | JMP Securities | main | Market Outperform | Market Outperform |
| May 24, 2023 | Raymond James | main | Outperform | Outperform |
| May 5, 2023 | JMP Securities | reit | — | Market Outperform |
About ACRES Commercial Realty Corp.
ACRES Commercial Realty Corp., a real estate investment trust (REIT), focuses on the origination, holding, and management of commercial real estate mortgage loans and equity investments in commercial real estate property in the United States. It invests in commercial real estate-related assets, including floating-rate first mortgage loans, first priority interests in first mortgage loans, subordinated interests in first mortgage loans, mezzanine financing, preferred equity investments, and commercial mortgage-backed securities. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was formerly known as Exantas Capital Corp. and changed its name to ACRES Commercial Realty Corp. in February 2021. ACRES Commercial Realty Corp. was incorporated in 2005 and is based in Uniondale, New York.
- Sector
- Real Estate
- Industry
- REIT - Mortgage
- Country
- United States
- Website
- acresreit.com
News
- KBRA Publishes Ratings for ACRES Commercial Realty Corp.
- Acrivon Announces Late-Breaking Oral Plenary Presentation of Early Phase 1/2 Clinical Results in AP3-Predicted Tumors for its First-in-Class WEE1/PKMYT1 Inhibitor ACR-2316 at the 38th EORTC-NCI-AACR Symposium
- Citizens Maintains Market Outperform on ACRES Commercial Realty, Lowers Price Target to $17
- ACRES Commercial Realty Corp. to Report Results for Third Quarter 2026
- Acrivon Advances ACR-7280, an Optimized, AP3-Enabled, Potential First-in-Class, Oral CDK11 Inhibitor Toward IND Filing in First Half of 2027
- CRISPR Therapeutics to Present Clinical Data on Zugocabtagene Geleucel (Zugo-cel) in Autoimmune Disease at the American College of Rheumatology (ACR) Convergence 2026
- Artiva Biotherapeutics Announces Multiple AlloNK® Data Presentations at the American College of Rheumatology (ACR) Convergence 2026
- ACRES Commercial (ACR) Moves 9.5% Higher: Will This Strength Last?
- ACRES Commercial Realty Announces Additional $5M Buyback Plan
- ACRES Commercial Realty Corp. Reauthorizes an Additional $5 Million Share Repurchase Program
Your note
Sign in to keep a note on ACR — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BRYANT DAVID J | Director | Stock Award(Grant) | May 6, 2024 | 39,963 |
| EAGLE POINT CREDIT MANAGEMENT LLC | Beneficial Owner of more than 10% of a Class of Security | Purchase | Oct 22, 2023 | 0 |
| EDWARDS KAREN K | Director | Stock Award(Grant) | May 6, 2024 | 9,524 |
| HART WILLIAM BAIRD JR | Director | Stock Award(Grant) | May 6, 2024 | 60,814 |
| ICKOWICZ GARY | Director | Stock Award(Grant) | May 6, 2024 | 25,629 |
| KESSLER STEVEN J | Director | Stock Award(Grant) | May 6, 2024 | 41,327 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 4.70% | 363,781 | 5.75M | Sep 29, 2024 |
| Nokomis Capital, L.l.c. | 3.38% | 261,708 | 4.13M | Sep 29, 2024 |
| Acadian Asset Management. LLC | 1.54% | 119,297 | 1.88M | Sep 29, 2024 |
| Gratia Capital, LLC | 1.29% | 100,000 | 1.58M | Sep 29, 2024 |
| Blackrock Inc. | 1.28% | 98,777 | 1.56M | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.79% | 61,346 | 969.27K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3.17% | 245,355 | 3.88M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 1.34% | 104,023 | 1.64M | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.45% | 34,467 | 544.58K | Oct 30, 2024 |
| Price (T.Rowe) Extended Equity Market Index Fund | 0.21% | 16,332 | 258.05K | Sep 29, 2024 |
| iShares Micro Cap ETF | 0.20% | 15,579 | 246.15K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.14% | 10,546 | 166.63K | Oct 30, 2024 |